Clindamycin phosphate13-1
|
|
Clindamycin phosphate13-1 Eigenschaften
- Dichte
- 1.47±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)
- pka
- 1.83±0.10(Predicted)
Sicherheit
Clindamycin phosphate13-1 Chemische Eigenschaften,Einsatz,Produktion Methoden
Clindamycin phosphate13-1 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Clindamycin phosphate13-1 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 3)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Beijing Comparison Pharmaceutical Technology Co., Ltd | 010-010-52878169 15801002657 |
sales@bjcomparison.com | China | 4717 | 58 |
Hubei Yangxin Medical Technology Co., Ltd. | 15374522761 |
3003392093@qq.com | China | 8706 | 55 |
Wuxi Helen Biotechnology Co., Ltd., | 0510-85629785 18013409632 |
sales@reading-chemicals.com | China | 14081 | 58 |
- Clindamycin phosphate13-1
- formic acid compound with (2R,3R,4S,5R,6R)-6-((1S,2S)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-((S)-methylsulfinyl)tetrahydro-2H-pyran-3-yl dihydrogen phosphate (2:5)
- Clindamycin Phosphate impurity 13-1
- Clindamycin Impurity 87 Formate
- 887402-20-2